Comparison of postoperative nausea and vomiting accoring to manual and target controlled infusion of remifentanil in gynecological patients undergoing pelviscopic surgery - Randomized controlled trial
Not Applicable
Completed
- Conditions
- Neoplasms
- Registration Number
- KCT0007703
- Lead Sponsor
- BCWORLD PHARM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Patients scheduled for elective gynecological surgery using pelviscopy under general anesthesia
Exclusion Criteria
(1) 18 years old or younger, 70 years old or older
(2) Pregnant women
(3) Allergic to remifentanil or use is contraindicated
(4) Administration of antiemetics or steroids within 24 hours before surgery
(5) Obesity with a body mass index of 35 kg/m^2 or more
(6) ASA classification III or higher
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of post operative nausea and vomiting
- Secondary Outcome Measures
Name Time Method post operative pain (NRS)